← Back to ENTA

Enanta Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 12/08/2026Dec 2025Filed 12/08/2026Jun 2025Filed 12/08/2026Mar 2025Filed 12/08/2026Dec 2024Filed 12/08/2026Jun 2024Filed 13/08/2025Mar 2024Filed 13/08/2025
$14$17$19$18$15$17$18$17
−$20−$13−$12−$18−$23−$22−$23−$31
−$0.67−$0.45−$0.42−$0.85−$1.06−$1.05−$1.07−$1.47
2929292121212121

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.